Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Common Stock | Options Exercise | $343K | +6.67K | +185.4% | $51.50 | 10.3K | Jun 28, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Options Exercise | $4.21K | +468 | +4.56% | $9.00 | 10.7K | Jun 28, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Sale | -$714K | -7.14K | -66.49% | $100.00 | 3.6K | Jun 28, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Stock Option | Options Exercise | $343K | +6.67K | +25% | $51.50 | 33.3K | Jun 28, 2021 | Common Stock | 6.67K | $51.50 | Direct | F3, F4 |
transaction | TNDM | Stock Option | Options Exercise | $4.21K | +468 | $9.00 | 0 | Jun 28, 2021 | Common Stock | 468 | $9.00 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents shares of common stock received upon exercise of a stock option award. |
F2 | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. |
F3 | The options vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
F4 | The expiration date for these options is 10 years from the date of grant. |
F5 | The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. |